727Tip A Randomised Phase III Study of Tremelimumab (T) Plus Durvalumab (D) with or Without Lenvatinib Combined with Concurrent Transarterial Chemoembolisation (TACE) Versus TACE Alone in Patients (pts) with Locoregional Hepatocellular Carcinoma (HCC): EMERALD-3
ANNALS OF ONCOLOGY（2022）
Key words
Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined